Keyuan Pharma Overview
- Year Founded
-
2004
- Status
-
Public
- Employees
-
650
- Stock Symbol
-
301281
- Investments
-
2
- Share Price
-
$4.25
- (As of Friday Closing)
Keyuan Pharma General Information
Description
Shandong Keyuan Pharmaceutical Co Ltd is engaged in the research and development, production, and sales of chemical raw materials and their preparations.
Contact Information
Website
www.keyuanpharm.comCorporate Office
- Keyuan Street, Shandong Shanghe Economic Development Zone
- Jinan, Shandong
- China
Corporate Office
- Keyuan Street, Shandong Shanghe Economic Development Zone
- Jinan, Shandong
- China
Keyuan Pharma Stock Performance
As of 20-Nov-2026, Keyuan Pharma’s stock price is $4.25. Its current market cap is $460M with 108M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $4.25 | $4.61 | $3.67 - $8.72 | $460M | 108M | 2.28M | $0.09 |
Keyuan Pharma Financials Summary
As of 30-Sep-2026, Keyuan Pharma has a trailing 12-month revenue of $83.9M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 757,539 | 420,817 | 381,615 | 428,325 |
| Revenue | 83,868 | 55,376 | 64,625 | 63,264 |
| EBITDA | 11,959 | 9,411 | 15,239 | 17,656 |
| Net Income | 10,217 | 2,302 | 8,424 | 10,889 |
| Total Assets | 293,660 | 241,209 | 212,665 | 207,371 |
| Total Debt | 32,601 | 16,057 | 6,255 | 0 |
Keyuan Pharma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Keyuan Pharma Signals
Keyuan Pharma Investments (2)
Keyuan Pharma’s most recent deal was a Later Stage VC with Drug Farm for . The deal was made on 13-Jul-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Drug Farm | 13-Jul-2026 | Later Stage VC | Drug Discovery | ||
| Beijing Nuokangda Pharmaceutical Technology | 11-Nov-2023 | Secondary Transaction - Private | Drug Discovery |
Keyuan Pharma ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Chemicals
Industry
Rank
Percentile
Commodity Chemicals
Subindustry
Rank
Percentile
Keyuan Pharma FAQs
-
When was Keyuan Pharma founded?
Keyuan Pharma was founded in 2004.
-
Where is Keyuan Pharma headquartered?
Keyuan Pharma is headquartered in Jinan, China.
-
What is the size of Keyuan Pharma?
Keyuan Pharma has 650 total employees.
-
What industry is Keyuan Pharma in?
Keyuan Pharma’s primary industry is Drug Discovery.
-
Is Keyuan Pharma a private or public company?
Keyuan Pharma is a Public company.
-
What is Keyuan Pharma’s stock symbol?
The ticker symbol for Keyuan Pharma is 301281.
-
What is the current stock price of Keyuan Pharma?
As of 20-Nov-2026 the stock price of Keyuan Pharma is $4.25.
-
What is the current market cap of Keyuan Pharma?
The current market capitalization of Keyuan Pharma is $460M.
-
What is Keyuan Pharma’s current revenue?
The trailing twelve month revenue for Keyuan Pharma is $83.9M.
-
What is Keyuan Pharma’s annual earnings per share (EPS)?
Keyuan Pharma’s EPS for 12 months was $0.09.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process